PUT - SPRINTER OPEN END - ELI LILLY & CO | Real-time Euronext Paris 10:49:07 2024-07-03 EDT | ||
| 9.235 EUR | -7.33% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 9.235 | -7.33% |
| 24-07-02 | 9.965 | +18.56% |
| 24-07-01 | 8.405 | -4.22% |
Real-time Euronext Paris
Last update July 03, 2024 at 10:49 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| CG50V | |
| ISIN | DE000VD8TVV4 |
| Date issued | 2024-06-28 |
| Strike | 1,002 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.88 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.5 € |
|---|---|
| Lowest since issue | 8.095 € |
| Spread | 0.03 € |
| Spread % | 0.34% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
906.7
USD
Average target price
870.3
USD
Spread / Average Target
-4.02%
- Stock Market
- Certificates
- CG50V Certificat
